130 related articles for article (PubMed ID: 8112965)
1. Irradiation pretreatment before fibroblast implantation in experimental PVR.
Velikay M; Stolba U; Wedrich A; Datlinger P; Binder S; Handl-Zeller L
Int Ophthalmol; 1993 Aug; 17(4):191-3. PubMed ID: 8112965
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of experimental proliferative vitreoretinopathy in rabbits].
Kuriyama S; Ohuchi T; Okada M; Yamakawa R; Yoshimura N; Honda Y
Nippon Ganka Gakkai Zasshi; 1990 Sep; 94(9):792-8. PubMed ID: 2248164
[TBL] [Abstract][Full Text] [Related]
3. Regular silicone and fluorosilicone oil in the prevention of retinal detachment caused by experimental proliferative vitreoretinopathy.
Alghadyan A; Peyman GA; Fizer C; Tawakol M; Liu KR; Yue B; Peace JH
Int Ophthalmol; 1988 Jan; 11(3):171-4. PubMed ID: 3417389
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of radiation therapy for experimental proliferative vitreoretinopathy in rabbits.
Kuriyama S; Ohuchi T; Yoshimura N; Honda Y; Hiraoka M; Abe M
Graefes Arch Clin Exp Ophthalmol; 1990; 228(6):552-5. PubMed ID: 2265771
[TBL] [Abstract][Full Text] [Related]
5. A refined experimental model for proliferative vitreoretinopathy.
Chandler DB; Quansah FA; Hida T; Machemer R
Graefes Arch Clin Exp Ophthalmol; 1986; 224(1):86-91. PubMed ID: 2417916
[TBL] [Abstract][Full Text] [Related]
6. High-energy electrons used to inhibit experimental intraocular proliferation and detachment.
Binder S; Skorpik C; Paroussis P; Kulnig W; Menapace R; Prokesch E
Ophthalmologica; 1987; 195(3):128-34. PubMed ID: 3696702
[TBL] [Abstract][Full Text] [Related]
7. Panretinal photocoagulation aggravates experimental proliferative vitreoretinopathy.
Algvere PV; Hallnäs K; Dafgård E; Höög A
Graefes Arch Clin Exp Ophthalmol; 1990; 228(5):461-6. PubMed ID: 2227493
[TBL] [Abstract][Full Text] [Related]
8. Induction of experimental proliferative vitreoretinopathy in the rabbit eye by intravitreal injections of fibroblast growth factor.
Baudouin C; Fredj-Reygrobellet D; Ettaiche M; Barritault D; Gastaud P; Lapalus P
Lens Eye Toxic Res; 1992; 9(3-4):505-11. PubMed ID: 1284520
[No Abstract] [Full Text] [Related]
9. Aclacinomycin A in the treatment of experimental proliferative vitreoretinopathy. Efficacy and toxicity in the rabbit eye.
Steinhorst UH; Chen EP; Hatchell DL; Samsa GP; Saloupis PT; Westendorf J; Machemer R
Invest Ophthalmol Vis Sci; 1993 Apr; 34(5):1753-60. PubMed ID: 8473115
[TBL] [Abstract][Full Text] [Related]
10. Suppression of experimental tractional retinal detachment by low-dose radiation therapy.
Meredith TA; Ficker L; Stevens R; Olkowski Z; Anderson M; Hartmann J; Crocker I
Arch Ophthalmol; 1988 May; 106(5):673-5. PubMed ID: 3358735
[TBL] [Abstract][Full Text] [Related]
11. Measurement of cellular proliferation within the vitreous during experimental proliferative vitreoretinopathy.
Yang CM; Olsen KR; Hernandez E; Cousins SW
Graefes Arch Clin Exp Ophthalmol; 1992; 230(1):66-71. PubMed ID: 1547971
[TBL] [Abstract][Full Text] [Related]
12. The antiproliferative effect of fractionized radiation therapy: optimization of dosage.
Velikay M; Stolba U; Wedrich A; Datlinger P; Akramian J; Binder S
Doc Ophthalmol; 1994; 87(3):265-9. PubMed ID: 7835195
[TBL] [Abstract][Full Text] [Related]
13. Treatment of intraocular proliferations with intravitreal steroids.
Machemer R; Sugita G; Tano Y
Trans Am Ophthalmol Soc; 1979; 77():171-80. PubMed ID: 545825
[TBL] [Abstract][Full Text] [Related]
14. The development of severe proliferative vitreoretinopathy after retinal detachment surgery. Grade B: a determining risk factor.
Bonnet M
Graefes Arch Clin Exp Ophthalmol; 1988; 226(3):201-5. PubMed ID: 3402740
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of growth stimulating activity of the vitreous during PVR.
Yang CM; Cousins SW
Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2436-42. PubMed ID: 1634341
[TBL] [Abstract][Full Text] [Related]
16. Improvement in efficacy of corticosteroid therapy in an animal model of proliferative vitreoretinopathy by pretreatment.
Chandler DB; Hida T; Sheta S; Proia AD; Machemer R
Graefes Arch Clin Exp Ophthalmol; 1987; 225(4):259-65. PubMed ID: 3653718
[TBL] [Abstract][Full Text] [Related]
17. Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy.
Khawly JA; Saloupis P; Hatchell DL; Machemer R
Graefes Arch Clin Exp Ophthalmol; 1991; 229(5):464-7. PubMed ID: 1937080
[TBL] [Abstract][Full Text] [Related]
18. [Clinical and experimental results in the treatment of massive periretinal proliferation (MPP), a retinal detachment with a most unfavorable prognosis].
Binder S
Wien Klin Wochenschr Suppl; 1982; 139():1-32. PubMed ID: 6763405
[TBL] [Abstract][Full Text] [Related]
19. N,N-dimethyladriamycin for treatment of experimental proliferative vitreoretinopathy: efficacy and toxicity on the rabbit retina.
Steinhorst UH; Chen EP; Machemer R; Hatchell DL
Exp Eye Res; 1993 Apr; 56(4):489-95. PubMed ID: 8500561
[TBL] [Abstract][Full Text] [Related]
20. Experimental Fibroplasia in the rabbit vitreous. Retinal detachment induced by autologous fibroblasts.
Algvere P; Kock E
Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1976 May; 199(3):215-22. PubMed ID: 1084704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
